Review




Structured Review

VectorBuilder GmbH shprmt5- 3
Shprmt5 3, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shprmt5-+3/lentiviral+plasmids/10__7554_slash_elife__101299-349-9-22
Average 90 stars, based on 1 article reviews
shprmt5- 3 - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Recombinant:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Sequencing:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Polymerase Chain Reaction:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Purification:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

SYBR Green Assay:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Reverse Transcription:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Extraction:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Modification:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Transfection:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.

Software:

Article Title: The context-dependent epigenetic and organogenesis programs determine 3D vs. 2D cellular fitness of MYC-driven murine liver cancer cells
Article Snippet: DOI: https://doi.org/10.7554/eLife.101299 23 of 35 Reagent type (species) or resource Designation Source or reference Identifiers Additional information Commercial assay or kit Kapa biosystems mouse genotyping extraction kit Kapa biosystems KK7352 Commercial assay or kit TDE1,TAGMENT DNA ENZYME,24 RXN Illumina 15027865 Commercial assay or kit RNeasy Plus Mini Kit (250) QIAGEN 74136 Commercial assay or kit Seahorse XF Real- Time ATP Rate Assay Kit Agilent 103592–100 Commercial assay or kit Seahorse XF Cell Mito Stress Test Kit Agilent 103015–100 Commercial assay or kit NucleoBond Xtra EF kits Takara Bio USA 740424–50 Chemical compound, drug Dulbecco’s Modified Eagle Medium Corning 15–013- CV Chemical compound, drug McCoy’s 5 A Medium Thermo Fischer Scientific 16600082 Chemical compound, drug L- Glutamine Corning A2916801 Chemical compound, drug Fetal bovine serum Sigma- Aldrich A5256701 Chemical compound, drug Penicillin/Streptomycin Thermo Fischer Scientific 15140122 Chemical compound, drug XF calibrant Agilent 100840–000 Chemical compound, drug XF DMEM medium Agilent 103575–100 Chemical compound, drug Glucose Agilent 103577–100 Chemical compound, drug pyruvate Agilent 103578–100 Chemical compound, drug L- glutamine Agilent 103579–100 Chemical compound, drug Tris HCl BioWorld 40120297–1 Chemical compound, drug Dithiothreitol Thermo Fischer Scientific A39255 Chemical compound, drug Bromophenol blue Thermo Fischer Scientific A18469.18 Chemical compound, drug Sodium dodecyl sulfate Thermo Fischer Scientific BP166- 500 Chemical compound, drug Glycerol Sigma G5516- 500ml Chemical compound, drug TWEEN 20 Bio- Rad 1706531 Chemical compound, drug Gibco PBS, pH 7.4 Thermo Fischer Scientific 10- 010- 072 Chemical compound, drug Formaldehyde Thermo Fischer Scientific F79- 1 Continued Continued on next page Fang, Singh et al. eLife 2025;14:RP101299.



Similar Products

90
VectorBuilder GmbH shprmt5- 3
Shprmt5 3, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shprmt5-+3/lentiviral+plasmids/10__7554_slash_elife__101299-349-9-22
Average 90 stars, based on 1 article reviews
shprmt5- 3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
VectorBuilder GmbH recombinant dna reagent shprmt5-3
Recombinant Dna Reagent Shprmt5 3, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shprmt5-+3/lentiviral+plasmids/pmc12055005-29-4-6
Average 90 stars, based on 1 article reviews
recombinant dna reagent shprmt5-3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Broad Institute Inc shprmt5 (2) (5′-agggactggaat acgctaatt-3′)
PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, <t>shPRMT5</t> hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also <xref ref-type=Figure S1 . " width="250" height="auto" />
Shprmt5 (2) (5′ Agggactggaat Acgctaatt 3′), supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shprmt5-+3/shprmt5+sequences/pmc05344794-116-0-5
Average 90 stars, based on 1 article reviews
shprmt5 (2) (5′-agggactggaat acgctaatt-3′) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Broad Institute Inc shprmt5 (1) 5'-gcgtttcaagagggagttcat-3
PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, <t>shPRMT5</t> hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also <xref ref-type=Figure S1 . " width="250" height="auto" />
Shprmt5 (1) 5' Gcgtttcaagagggagttcat 3, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/shprmt5-+3/shprmt5+sequences/pmc05344794-115-0-4
Average 90 stars, based on 1 article reviews
shprmt5 (1) 5'-gcgtttcaagagggagttcat-3 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, shPRMT5 hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also <xref ref-type=Figure S1 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, shPRMT5 hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also Figure S1 .

Article Snippet: shPRMT5 (2) (5′-AGGGACTGGAAT ACGCTAATT-3′) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Staining, Cell Culture, Clonogenic Cell Survival Assay

PRMT5 Promotes Homologous Recombination-Mediated DSB Repair Independently of ATM Activation (A) HeLa-shCTRL and shPRMT5 cells were stimulated with 3Gy IR and RAD51 foci analyzed 6 hr later. Quantification of number of cells with >10 RAD51 foci is shown below (mean ± SEM; ∗∗ p = 0.006; n = 3). (B) Quantification of RPA foci in CENPF-positive (late S/G2) cells 8 hr after 3Gy IR is shown (mean ± SEM; ∗∗ p = 0.006; n = 3). (C) Time course of phosphorylated and total protein levels is shown. (D) U2OS-DR3 cells were treated with siRNA as indicated before transfection of I - Sce1 and myc-PRMT5. The number of GFP-positive cells (HR proficient) was determined by flow cytometry (mean ± SD; n = 3). (E) PRMT5-depleted cells were treated with increasing doses of camptothecin (CPT; left panel) or Olaparib (right panel), and survival was determined by colony assay (mean ± SD; n = 3). (F) Cells were treated with CPT (1 μM) for the time points indicated and immunoblotted for phosphorylated and total proteins. Scale bar, 10 μm. See also <xref ref-type=Figure S2 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Promotes Homologous Recombination-Mediated DSB Repair Independently of ATM Activation (A) HeLa-shCTRL and shPRMT5 cells were stimulated with 3Gy IR and RAD51 foci analyzed 6 hr later. Quantification of number of cells with >10 RAD51 foci is shown below (mean ± SEM; ∗∗ p = 0.006; n = 3). (B) Quantification of RPA foci in CENPF-positive (late S/G2) cells 8 hr after 3Gy IR is shown (mean ± SEM; ∗∗ p = 0.006; n = 3). (C) Time course of phosphorylated and total protein levels is shown. (D) U2OS-DR3 cells were treated with siRNA as indicated before transfection of I - Sce1 and myc-PRMT5. The number of GFP-positive cells (HR proficient) was determined by flow cytometry (mean ± SD; n = 3). (E) PRMT5-depleted cells were treated with increasing doses of camptothecin (CPT; left panel) or Olaparib (right panel), and survival was determined by colony assay (mean ± SD; n = 3). (F) Cells were treated with CPT (1 μM) for the time points indicated and immunoblotted for phosphorylated and total proteins. Scale bar, 10 μm. See also Figure S2 .

Article Snippet: shPRMT5 (2) (5′-AGGGACTGGAAT ACGCTAATT-3′) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Homologous Recombination, Activation Assay, Transfection, Flow Cytometry, Colony Assay

PRMT5 Binds to and Methylates RUVBL1 at R205 (A) SYPRO Ruby stain of PRMT5 protein complexes isolated from 293T cells stably expressing tetracycline-regulated TAP-tagged catalytically inactive PRMT5 (PRMT5 MD) is shown. (B) Co-immunoprecipitation of myc-PRMT5 MD with FLAG-tagged RUVBL1/RUVBL2 is shown. (C) Endogenous immunoprecipitation of RUVBL1 from HeLa cells co-immunoprecipitates endogenous PRMT5. (D) Transfected HeLa-shCTRL or shPRMT5 cell lines were treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. FLAG-RUVBL1 was immunoprecipitated, and incorporated methyl groups were detected by SDS-PAGE followed by autoradiograph. Quantification of [ 3 H]-methyl signal intensity adjusted for immunoprecipitation (IP) and normalized to shCTRL is shown (mean ± SD; ∗ p = 0.03 and ∗∗∗ p = 0.0009). (E) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1 or FLAG-RUVBL1-R205K, treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. Quantification of [ 3 H]-methyl signal intensity adjusted for IP and normalized to wild-type is shown (mean ± SD; n = 3). (F) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa-shCTRL or shPRMT5 cell lines is shown. (G) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa cells treated with Adox (100 μM; 24 hr) or GSK591 (5 μM; 24 hr) is shown. (H) Transfected 293T cells were damaged with 10Gy IR and myc-PRMT5 MD immunoprecipitated. Associated RUVBL1 was detected by FLAG immunoblotting. (I) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1, treated with CHX/CAM, and labeled with [ 3 H]-methyl methionine for 4 hr before treating with 10Gy IR are shown. (J) Immunoblot analysis of whole-cell lysates transfected with FLAG-RUVBL1 and damaged with 10Gy IR. See also .

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Binds to and Methylates RUVBL1 at R205 (A) SYPRO Ruby stain of PRMT5 protein complexes isolated from 293T cells stably expressing tetracycline-regulated TAP-tagged catalytically inactive PRMT5 (PRMT5 MD) is shown. (B) Co-immunoprecipitation of myc-PRMT5 MD with FLAG-tagged RUVBL1/RUVBL2 is shown. (C) Endogenous immunoprecipitation of RUVBL1 from HeLa cells co-immunoprecipitates endogenous PRMT5. (D) Transfected HeLa-shCTRL or shPRMT5 cell lines were treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. FLAG-RUVBL1 was immunoprecipitated, and incorporated methyl groups were detected by SDS-PAGE followed by autoradiograph. Quantification of [ 3 H]-methyl signal intensity adjusted for immunoprecipitation (IP) and normalized to shCTRL is shown (mean ± SD; ∗ p = 0.03 and ∗∗∗ p = 0.0009). (E) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1 or FLAG-RUVBL1-R205K, treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. Quantification of [ 3 H]-methyl signal intensity adjusted for IP and normalized to wild-type is shown (mean ± SD; n = 3). (F) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa-shCTRL or shPRMT5 cell lines is shown. (G) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa cells treated with Adox (100 μM; 24 hr) or GSK591 (5 μM; 24 hr) is shown. (H) Transfected 293T cells were damaged with 10Gy IR and myc-PRMT5 MD immunoprecipitated. Associated RUVBL1 was detected by FLAG immunoblotting. (I) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1, treated with CHX/CAM, and labeled with [ 3 H]-methyl methionine for 4 hr before treating with 10Gy IR are shown. (J) Immunoblot analysis of whole-cell lysates transfected with FLAG-RUVBL1 and damaged with 10Gy IR. See also .

Article Snippet: shPRMT5 (2) (5′-AGGGACTGGAAT ACGCTAATT-3′) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Staining, Isolation, Stable Transfection, Expressing, Immunoprecipitation, Transfection, Labeling, SDS Page, Autoradiography, Western Blot

PRMT5-Dependent Methylation of RUVBL1 at R205 Regulates 53BP1 Removal and Is Epistatic with TIP60 (A) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and cell viability was assessed by colony survival. Results are expressed normalized to the respective non-treatment control (mean ± SD; n = 3). (B and C) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (B) or CENPF/RPA (C) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (D and E) HeLa-shCTRL or RUVBL1-R205K cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (D) or CENPF/RPA (E) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (F) Validation of siTIP60 knockdown is shown. (G) Cells were transfected with si53BP1 and the number of mitosin-positive cells with >10 RAD51 foci was quantified (mean ± SEM; n = 3). (H) Cells were transfected with si53BP1 and the number of CENPF-positive cells with >10 RPA foci was quantified (mean ± SEM; n = 3). (I) Validation of 53BP1 siRNA SMARTpool. See also <xref ref-type=Figure S6 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5-Dependent Methylation of RUVBL1 at R205 Regulates 53BP1 Removal and Is Epistatic with TIP60 (A) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and cell viability was assessed by colony survival. Results are expressed normalized to the respective non-treatment control (mean ± SD; n = 3). (B and C) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (B) or CENPF/RPA (C) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (D and E) HeLa-shCTRL or RUVBL1-R205K cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (D) or CENPF/RPA (E) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (F) Validation of siTIP60 knockdown is shown. (G) Cells were transfected with si53BP1 and the number of mitosin-positive cells with >10 RAD51 foci was quantified (mean ± SEM; n = 3). (H) Cells were transfected with si53BP1 and the number of CENPF-positive cells with >10 RPA foci was quantified (mean ± SEM; n = 3). (I) Validation of 53BP1 siRNA SMARTpool. See also Figure S6 .

Article Snippet: shPRMT5 (2) (5′-AGGGACTGGAAT ACGCTAATT-3′) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Methylation, Transfection, Control, Staining, Biomarker Discovery, Knockdown

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet:

Article Snippet: shPRMT5 (2) (5′-AGGGACTGGAAT ACGCTAATT-3′) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Recombinant, Staining, Mutagenesis, Plasmid Preparation, Sequencing, Negative Control, Software

PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, shPRMT5 hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also <xref ref-type=Figure S1 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Is Required for Effective Double-Strand Break Repair (A) HeLa-shCTRL, shPRMT5 hairpin 1 (1), and shPRMT5 hairpin 2 (2) cells were stimulated with 3Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated. (B and C) Quantification of (A) is shown (mean ± SEM; n = 3). (D) Reconstitution of PRMT5-depleted HeLa cells with wild-type or catalytically inactive (MD) PRMT5. Quantification of 53BP1 foci 24 hr after IR (3 Gy) is shown (mean ± SEM; n = 3). (E) Primary, non-immortalized prmt5 f/f and prmt5 f/f ;CreERT2 mouse embryonic fibroblasts (MEFs) were cultured in the absence or presence of 4-hydroxy-tamoxifen (4-OHT; 500 nM for 24 hr), followed by 4 days in 4-OHT-deficient media, and then immunoblotted for PRMT5. (F–H) Cells were stimulated with 5Gy IR and co-stained for γH2AX and 53BP1 foci at the time points indicated (F). Quantification of γH2AX (G) and 53BP1 (H) foci is shown (mean ± SEM). (I) HeLa-shPRMT5 cells were exposed to increasing doses of IR and cell viability was determined by colony survival assay (mean ± SD; n = 3). (J) Analysis of chromatid gaps and breaks per metaphase is shown (mean ± SEM; ∗∗ p < 0.0098; n = 3). (K) Quantification of 53BP1 foci in mitosin-positive (late S/G2) cells 24 hr after 3Gy IR is shown (mean ± SEM; n = 3). Scale bar, 10 μm. See also Figure S1 .

Article Snippet: shPRMT5 (1) (5′-GCGTTTCAAGAGGGAGTTCAT-3) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Staining, Cell Culture, Clonogenic Cell Survival Assay

PRMT5 Promotes Homologous Recombination-Mediated DSB Repair Independently of ATM Activation (A) HeLa-shCTRL and shPRMT5 cells were stimulated with 3Gy IR and RAD51 foci analyzed 6 hr later. Quantification of number of cells with >10 RAD51 foci is shown below (mean ± SEM; ∗∗ p = 0.006; n = 3). (B) Quantification of RPA foci in CENPF-positive (late S/G2) cells 8 hr after 3Gy IR is shown (mean ± SEM; ∗∗ p = 0.006; n = 3). (C) Time course of phosphorylated and total protein levels is shown. (D) U2OS-DR3 cells were treated with siRNA as indicated before transfection of I - Sce1 and myc-PRMT5. The number of GFP-positive cells (HR proficient) was determined by flow cytometry (mean ± SD; n = 3). (E) PRMT5-depleted cells were treated with increasing doses of camptothecin (CPT; left panel) or Olaparib (right panel), and survival was determined by colony assay (mean ± SD; n = 3). (F) Cells were treated with CPT (1 μM) for the time points indicated and immunoblotted for phosphorylated and total proteins. Scale bar, 10 μm. See also <xref ref-type=Figure S2 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Promotes Homologous Recombination-Mediated DSB Repair Independently of ATM Activation (A) HeLa-shCTRL and shPRMT5 cells were stimulated with 3Gy IR and RAD51 foci analyzed 6 hr later. Quantification of number of cells with >10 RAD51 foci is shown below (mean ± SEM; ∗∗ p = 0.006; n = 3). (B) Quantification of RPA foci in CENPF-positive (late S/G2) cells 8 hr after 3Gy IR is shown (mean ± SEM; ∗∗ p = 0.006; n = 3). (C) Time course of phosphorylated and total protein levels is shown. (D) U2OS-DR3 cells were treated with siRNA as indicated before transfection of I - Sce1 and myc-PRMT5. The number of GFP-positive cells (HR proficient) was determined by flow cytometry (mean ± SD; n = 3). (E) PRMT5-depleted cells were treated with increasing doses of camptothecin (CPT; left panel) or Olaparib (right panel), and survival was determined by colony assay (mean ± SD; n = 3). (F) Cells were treated with CPT (1 μM) for the time points indicated and immunoblotted for phosphorylated and total proteins. Scale bar, 10 μm. See also Figure S2 .

Article Snippet: shPRMT5 (1) (5′-GCGTTTCAAGAGGGAGTTCAT-3) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Homologous Recombination, Activation Assay, Transfection, Flow Cytometry, Colony Assay

PRMT5 Binds to and Methylates RUVBL1 at R205 (A) SYPRO Ruby stain of PRMT5 protein complexes isolated from 293T cells stably expressing tetracycline-regulated TAP-tagged catalytically inactive PRMT5 (PRMT5 MD) is shown. (B) Co-immunoprecipitation of myc-PRMT5 MD with FLAG-tagged RUVBL1/RUVBL2 is shown. (C) Endogenous immunoprecipitation of RUVBL1 from HeLa cells co-immunoprecipitates endogenous PRMT5. (D) Transfected HeLa-shCTRL or shPRMT5 cell lines were treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. FLAG-RUVBL1 was immunoprecipitated, and incorporated methyl groups were detected by SDS-PAGE followed by autoradiograph. Quantification of [ 3 H]-methyl signal intensity adjusted for immunoprecipitation (IP) and normalized to shCTRL is shown (mean ± SD; ∗ p = 0.03 and ∗∗∗ p = 0.0009). (E) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1 or FLAG-RUVBL1-R205K, treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. Quantification of [ 3 H]-methyl signal intensity adjusted for IP and normalized to wild-type is shown (mean ± SD; n = 3). (F) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa-shCTRL or shPRMT5 cell lines is shown. (G) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa cells treated with Adox (100 μM; 24 hr) or GSK591 (5 μM; 24 hr) is shown. (H) Transfected 293T cells were damaged with 10Gy IR and myc-PRMT5 MD immunoprecipitated. Associated RUVBL1 was detected by FLAG immunoblotting. (I) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1, treated with CHX/CAM, and labeled with [ 3 H]-methyl methionine for 4 hr before treating with 10Gy IR are shown. (J) Immunoblot analysis of whole-cell lysates transfected with FLAG-RUVBL1 and damaged with 10Gy IR. See also .

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5 Binds to and Methylates RUVBL1 at R205 (A) SYPRO Ruby stain of PRMT5 protein complexes isolated from 293T cells stably expressing tetracycline-regulated TAP-tagged catalytically inactive PRMT5 (PRMT5 MD) is shown. (B) Co-immunoprecipitation of myc-PRMT5 MD with FLAG-tagged RUVBL1/RUVBL2 is shown. (C) Endogenous immunoprecipitation of RUVBL1 from HeLa cells co-immunoprecipitates endogenous PRMT5. (D) Transfected HeLa-shCTRL or shPRMT5 cell lines were treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. FLAG-RUVBL1 was immunoprecipitated, and incorporated methyl groups were detected by SDS-PAGE followed by autoradiograph. Quantification of [ 3 H]-methyl signal intensity adjusted for immunoprecipitation (IP) and normalized to shCTRL is shown (mean ± SD; ∗ p = 0.03 and ∗∗∗ p = 0.0009). (E) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1 or FLAG-RUVBL1-R205K, treated with CHX/CAM and labeled with [ 3 H]-methyl methionine. Quantification of [ 3 H]-methyl signal intensity adjusted for IP and normalized to wild-type is shown (mean ± SD; n = 3). (F) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa-shCTRL or shPRMT5 cell lines is shown. (G) Immunoblot analysis of endogenous RUVBL1-R205me2s in HeLa cells treated with Adox (100 μM; 24 hr) or GSK591 (5 μM; 24 hr) is shown. (H) Transfected 293T cells were damaged with 10Gy IR and myc-PRMT5 MD immunoprecipitated. Associated RUVBL1 was detected by FLAG immunoblotting. (I) Autoradiograph and immunoblots of 293T cells transfected with FLAG-RUVBL1, treated with CHX/CAM, and labeled with [ 3 H]-methyl methionine for 4 hr before treating with 10Gy IR are shown. (J) Immunoblot analysis of whole-cell lysates transfected with FLAG-RUVBL1 and damaged with 10Gy IR. See also .

Article Snippet: shPRMT5 (1) (5′-GCGTTTCAAGAGGGAGTTCAT-3) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Staining, Isolation, Stable Transfection, Expressing, Immunoprecipitation, Transfection, Labeling, SDS Page, Autoradiography, Western Blot

PRMT5-Dependent Methylation of RUVBL1 at R205 Regulates 53BP1 Removal and Is Epistatic with TIP60 (A) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and cell viability was assessed by colony survival. Results are expressed normalized to the respective non-treatment control (mean ± SD; n = 3). (B and C) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (B) or CENPF/RPA (C) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (D and E) HeLa-shCTRL or RUVBL1-R205K cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (D) or CENPF/RPA (E) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (F) Validation of siTIP60 knockdown is shown. (G) Cells were transfected with si53BP1 and the number of mitosin-positive cells with >10 RAD51 foci was quantified (mean ± SEM; n = 3). (H) Cells were transfected with si53BP1 and the number of CENPF-positive cells with >10 RPA foci was quantified (mean ± SEM; n = 3). (I) Validation of 53BP1 siRNA SMARTpool. See also <xref ref-type=Figure S6 . " width="100%" height="100%">

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet: PRMT5-Dependent Methylation of RUVBL1 at R205 Regulates 53BP1 Removal and Is Epistatic with TIP60 (A) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and cell viability was assessed by colony survival. Results are expressed normalized to the respective non-treatment control (mean ± SD; n = 3). (B and C) HeLa-shCTRL or shPRMT5 cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (B) or CENPF/RPA (C) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (D and E) HeLa-shCTRL or RUVBL1-R205K cells were siRNA transfected, exposed to 3Gy IR, and stained for 53BP1 (D) or CENPF/RPA (E) foci 24 and 8 hr after damage, respectively (mean ± SEM; n = 3). (F) Validation of siTIP60 knockdown is shown. (G) Cells were transfected with si53BP1 and the number of mitosin-positive cells with >10 RAD51 foci was quantified (mean ± SEM; n = 3). (H) Cells were transfected with si53BP1 and the number of CENPF-positive cells with >10 RPA foci was quantified (mean ± SEM; n = 3). (I) Validation of 53BP1 siRNA SMARTpool. See also Figure S6 .

Article Snippet: shPRMT5 (1) (5′-GCGTTTCAAGAGGGAGTTCAT-3) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Methylation, Transfection, Control, Staining, Biomarker Discovery, Knockdown

Journal: Molecular Cell

Article Title: PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination

doi: 10.1016/j.molcel.2017.01.019

Figure Lengend Snippet:

Article Snippet: shPRMT5 (1) (5′-GCGTTTCAAGAGGGAGTTCAT-3) , Broad Institute GPP Web Portal , http://portals.broadinstitute.org/gpp/public.

Techniques: Recombinant, Staining, Mutagenesis, Plasmid Preparation, Sequencing, Negative Control, Software